InVitria

InVitria is a leading developer and manufacturer of recombinant proteins and supplements. Their products are used by pioneers in biomanufacturing and the final formulation of vaccines, biologic medicines, cell therapies, gene therapies, and regenerative medicines. Their products are designed for sustainability, utilising their ExpressTec system, which uses plants as the production host and eliminates animal-derived components from gene to final product.

InVitria provides fully recombinant, fully human protein supplements suitable for regulatory-friendly, serum-reduced, or serum-free culture of stem cells, isolated primary cells, and more. All products are biosynthetically manufactured in the USA using recombinant DNA technology in an animal-free host at an ISO 9001:2015 certified facility. These products are appropriate for RUO and cGMP applications and facilitate the reduction or elimination of serum, serum-purified proteins, and serum-derived contaminants from cell culture media at any scale.